Gotrade News - Nine Wall Street names posted sharp single-day moves in yesterday's session. Catalysts ranged from job cuts and clinical trial deaths to a sudden chief financial officer resignation.
Key Points
- Moves were driven by stock-specific catalysts rather than a broad market theme.
- Nike trimmed 1,400 employees as its "Win Now" turnaround pushes ahead.
- Zimmer Biomet plunged to a 13-year low after its finance chief resigned abruptly.
| Ticker | Move | Catalyst | |---|---|---| | VISN | -49% | After $10 special dividend | | ERAS | -48% | Patient death in clinical trial | | RMBS | -21% | Baird downgrade to Neutral | | NVTS | sharp drop | Profit-taking after 100%+ gain | | CLS | -14% | Profit-taking from all-time high | | RLAY | sharp drop | Profit-taking from April 74% jump | | SRAD | 52-week low | Weak Q1 and 14.3% PT downgrade | | ZBH | -10.5% | Sudden CFO resignation | | NKE | down | Layoffs of 1,400 global staff |
Nike announced 1,400 global layoffs, less than 2% of total headcount, according to Insidermonkey. The technology department took the hardest hit, spanning operations in North America, Asia, and Europe.
CEO Elliott Hill is leading the "Win Now" strategy to reshape the technology team and modernize Air manufacturing. The April cuts follow 775 positions trimmed at US distribution centers in January 2026.
Zimmer Biomet plunged 10.53% to $82.84 after CFO Suketu Upadhyay departed abruptly after seven years in the role. Paul Stellato, Chief Accounting Officer, was named interim CFO while a permanent search runs.
The drop surprised investors because Q1 net income jumped 30.8% to $238.1 million on 9.3% sales growth. Markets read the executive exit as more material than the strong quarterly print, according to Insidermonkey.
Celestica fell 14.37% to $361.54 after hitting a record $423.25 the prior session. The slide reflected profit-taking even as the firm lifted full-year revenue guidance to $19 billion from $17 billion.
Rambus shed 21.17% to $111.27 after Baird downgraded to Neutral. Baird flagged a slowdown in RDIMM memory modules and DRAM shortages persisting through 2027.
